Viewing Study NCT01137669


Ignite Creation Date: 2025-12-24 @ 10:51 PM
Ignite Modification Date: 2026-02-07 @ 7:13 PM
Study NCT ID: NCT01137669
Status: COMPLETED
Last Update Posted: 2017-01-09
First Post: 2010-06-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: ZOSTAVAX® in Renal Transplant Patients
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Herpes Zoster View
Keywords:

Keywords

Keyword Brief Keyword Text View
None immunocompromised,parent protocol,shingles,varicella-zoster virus,ZOSTAVAX® View